228 related articles for article (PubMed ID: 10646871)
1. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ.
Bindels EM; Vermey M; van den Beemd R; Dinjens WN; Van Der Kwast TH
Cancer Res; 2000 Jan; 60(1):177-83. PubMed ID: 10646871
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells.
Rebel JM; Thijssen CD; Vermey M; Delouvée A; Zwarthoff EC; Van der Kwast TH
Cancer Res; 1994 Oct; 54(20):5488-92. PubMed ID: 7923182
[TBL] [Abstract][Full Text] [Related]
3. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
4. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas.
De Medina SG; Popov Z; Chopin DK; Southgate J; Tucker GC; Delouvée A; Thiery JP; Radvanyi F
Oncogene; 1999 Oct; 18(41):5722-6. PubMed ID: 10523852
[TBL] [Abstract][Full Text] [Related]
5. Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors.
Moersig W; Horn S; Hilker M; Mayer E; Oelert H
Thorac Cardiovasc Surg; 2002 Feb; 50(1):45-8. PubMed ID: 11847604
[TBL] [Abstract][Full Text] [Related]
6. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor.
Bindels EM; Vermey M; Rebel JM; Zwarthoff EC; Van Der Kwast TH
Exp Cell Res; 1997 Sep; 235(2):395-402. PubMed ID: 9299164
[TBL] [Abstract][Full Text] [Related]
9. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP
Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervix.
Jeffers MD; Paxton J; Bolger B; Richmond JA; Kennedy JH; McNicol AM
Gynecol Oncol; 1997 Mar; 64(3):481-6. PubMed ID: 9062155
[TBL] [Abstract][Full Text] [Related]
11. Expression of classic cadherins type I in urothelial neoplastic progression.
Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC
Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290
[TBL] [Abstract][Full Text] [Related]
12. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
[TBL] [Abstract][Full Text] [Related]
13. Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells.
Huygens A; Kamuhabwa AR; Roskams T; VAN Cleynenbreugel B; VAN Poppel H; de Witte PA
J Urol; 2005 Jul; 174(1):69-72. PubMed ID: 15947580
[TBL] [Abstract][Full Text] [Related]
14. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies.
Bryan RT; Atherfold PA; Yeo Y; Jones LJ; Harrison RF; Wallace DM; Jankowski JA
J Pathol; 2008 Jun; 215(2):184-94. PubMed ID: 18393367
[TBL] [Abstract][Full Text] [Related]
15. Dominant role of E-cadherin in the progression of bladder cancer.
Imao T; Koshida K; Endo Y; Uchibayashi T; Sasaki T; Namiki M
J Urol; 1999 Feb; 161(2):692-8. PubMed ID: 9915485
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
Mahnken A; Kausch I; Feller AC; Krüger S
Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
[TBL] [Abstract][Full Text] [Related]
17. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
Ross JS; Cheung C; Sheehan C; del Rosario AD; Bui HX; Fisher HA
Diagn Cytopathol; 1996 Jun; 14(4):310-5. PubMed ID: 8725130
[TBL] [Abstract][Full Text] [Related]
19. Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.
Laidler P; Gil D; Pituch-Noworolska A; Ciołczyk D; Ksiazek D; Przybyło M; Lityńska A
Acta Biochim Pol; 2000; 47(4):1159-70. PubMed ID: 11996105
[TBL] [Abstract][Full Text] [Related]
20. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma.
Vessey CJ; Wilding J; Folarin N; Hirano S; Takeichi M; Soutter P; Stamp GW; Pignatelli M
J Pathol; 1995 Jun; 176(2):151-9. PubMed ID: 7636625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
